A phase I single and multiple dose study of NP03 for the treatment of Huntington's disease.
Phase of Trial: Phase I
Latest Information Update: 14 May 2016
At a glance
- Drugs Lithium (Primary)
- Indications Huntington's disease
- Focus Adverse reactions; Pharmacokinetics
- 14 May 2016 New trial record